Sign In
Buy BLCM
$0.0748
+0 (+0%)
At Close: Jun 03, 2024
Gang of five men attempt to steal dog from woman
04:26pm, Tuesday, 09'th Jun 2020
Detectives are urging anyone who was in the area and saw anything that may help their investigation to come forward
Woman fights off gang who tried to steal her dog as she walked it
11:53am, Tuesday, 09'th Jun 2020
Dog thieves snatched woman's wrist and tried to yank the lead from her hand
Celyad's Positive Data And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:CYAD)
06:55am, Friday, 05'th Jun 2020
Celyad reports positive data for allogenic CAR-T. Sanofi is approved in the EU for Sarclisa in Multiple Myeloma. Abiomed gets IND for its Covid-19 iNKT therapy.
Man pleads guilty to grooming offences
07:13am, Thursday, 04'th Jun 2020
He believed he was talking to a 14-year-old girl, but was actually an adult who reported it to the police
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
01:00pm, Wednesday, 03'rd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9 th -12 th , connecting 47 presenting small and microcap companies with distinguished investors from aroun
Bellicum Pharmaceuticals Says M.D. Anderson To Resume, On Phased Basis, Selected Research, Manufacturing Activities
10:17am, Wednesday, 03'rd Jun 2020Top Ranked Momentum Stocks to Buy for June 1st
02:45pm, Monday, 01'st Jun 2020
Top Ranked Momentum Stocks to Buy for June 1st
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:06pm, Friday, 29'th May 2020
The Compensation Committee of the Board of Directors approved the grants with an effective date of May 29, 2020. The stock options were granted as inducements material to the employees entering into
Bellicum Announces The Publication Of Its Preclinical Data From Its GoCAR-NK Cell Program
08:11pm, Wednesday, 27'th May 2020Bellicum Announces Publication of Data for GoCAR-NK™ Cell Program
08:05pm, Wednesday, 27'th May 2020
HOUSTON, May 27, 2020 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced the.
Bellicum to Participate in Two Upcoming Virtual Investor Conferences
11:30am, Wednesday, 27'th May 2020
HOUSTON, May 27, 2020 -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that.
Bellicum Announces Publication of Data for GoCAR-NK™ Cell Program
12:00am, Wednesday, 27'th May 2020All You Need to Know About Bellicum Pharmaceuticals (BLCM) Rating Upgrade to Strong Buy
04:00pm, Friday, 22'nd May 2020
Bellicum Pharmaceuticals (BLCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
